Private offering places one-year 4% debentures with multiple investors
By Devika Patel
Knoxville, Tenn., Sept. 27 - Medgenics, Inc. said it took in $4 million through a private placement of 4% convertible unsecured debentures. The offering priced for between $1 million and $3 million on Aug. 24.
The debentures mature in one year and are convertible into shares at 13p. The conversion price represents a 57.58% premium to the 8.25p closing share price on Aug. 23.
The debentures will automatically convert upon the company completing an underwritten public offering of stock which raises at least $6 million at a conversion price equal to the lesser of 13p and 75% of the public offering price of the stock.
Investors also received 75% warrant coverage. The warrants will be exercisable at 16p for five years. The strike price reflects a 93.94% premium to the closing share price on Aug. 23.
Investors included the Kanter Family Foundation and CIBC Trust Co. (Bahamas) Ltd., which each purchased $100,000 of debentures. In addition, Chicago Investments, Inc. purchased $50,000 of debentures.
Based in Vienna, Va., Medgenics is a biotechnology company and developer of associated medical equipment.
Issuer: | Medgenics, Inc.
|
Issue: | Convertible unsecured debentures
|
Amount: | $4 million
|
Maturity: | One year
|
Coupon: | 4%
|
Price: | Par
|
Yield: | 4%
|
Conversion price: | 13p
|
Warrants: | 75% coverage
|
Warrant expiration: | Five years
|
Warrant strike price: | 16p
|
Investors: | Kanter Family Foundation (for $100,000), CIBC Trust Co. (Bahamas) Ltd. (for $100,000), Chicago Investments, Inc. (for $50,000)
|
Pricing date: | Aug. 24
|
Stock symbol: | London: MEDG
|
Stock price: | 8.97p at close Aug. 24
|
Market capitalization: | £13.01 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.